Gert J Ossenkoppele Selected Research

Gert J Ossenkoppele Research Topics

Disease

72	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2022 - 02/2003
29	Leukemia 01/2022 - 02/2003
23	Neoplasms (Cancer) 11/2019 - 06/2002
14	Residual Neoplasm 01/2021 - 02/2003
12	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019 - 04/2004
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2017 - 11/2007
5	Pathologic Complete Response 12/2020 - 10/2005
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2011 - 07/2002
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2010 - 04/2005
5	Lymphoma (Lymphomas) 04/2010 - 03/2004
5	B-Cell Lymphoma (Lymphoma, B Cell) 01/2008 - 04/2005
3	Acute Promyelocytic Leukemia 12/2020 - 08/2010
3	Refractory Anemia 01/2020 - 09/2009
3	Cytopenia 01/2019 - 08/2009
3	Blister (Bulla) 11/2015 - 01/2014
3	Philadelphia Chromosome 03/2015 - 11/2007
2	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 10/2010
2	Myeloid Leukemia (Leukemia, Myelocytic) 02/2016 - 01/2006
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2015 - 04/2013
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 05/2014 - 01/2014
2	Wilms Tumor (Wilm's Tumor) 04/2013 - 01/2007
2	Breast Neoplasms (Breast Cancer) 05/2007 - 02/2003
2	Necrosis 08/2006 - 01/2003
2	Hyperthermia 01/2005 - 09/2003
1	Refractory Anemia with Excess of Blasts (RAEM) 01/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2019

Drug/Important Bio-Agent (IBA)

16	AntigensIBA 10/2018 - 08/2004
9	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2017 - 04/2004
8	Peptides (Polypeptides)IBA 11/2015 - 01/2010
7	VaccinesIBA 10/2018 - 01/2006
7	Imatinib Mesylate (Gleevec)FDA Link 08/2013 - 11/2007
6	Pharmaceutical PreparationsIBA 01/2022 - 03/2011
6	Azacitidine (5 Azacytidine)FDA Link 12/2020 - 07/2012
6	Proteins (Proteins, Gene)FDA Link 02/2014 - 06/2002
5	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2020 - 08/2010
5	Tyrosine Kinase InhibitorsIBA 08/2017 - 04/2011
5	invariant chain (Ii-Key)IBA 06/2014 - 03/2010
4	Decitabine FDA Link 04/2022 - 08/2019
4	Biomarkers (Surrogate Marker)IBA 12/2021 - 03/2010
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2007 - 07/2002
3	Lenalidomide (CC 5013)FDA Link 05/2021 - 04/2013
3	nilotinib FDA Link 08/2017 - 11/2007
3	AnthracyclinesIBA 06/2017 - 08/2010
3	Daunorubicin (Cerubidine)FDA LinkGeneric 06/2017 - 10/2005
3	Interleukin-4 (Interleukin 4)IBA 11/2015 - 01/2003
3	Histocompatibility Antigens Class IIIBA 04/2011 - 03/2010
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2007 - 02/2003
3	valspodar (PSC 833)IBA 10/2005 - 02/2003
3	CaspasesIBA 04/2005 - 06/2002
2	Clofarabine (Clolar)FDA Link 01/2022 - 03/2017
2	Immunoconjugates (Immunoconjugate)IBA 01/2019 - 11/2004
2	RNA (Ribonucleic Acid)IBA 01/2018 - 01/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2010
2	EnzymesIBA 02/2016 - 02/2014
2	AminopeptidasesIBA 02/2016 - 10/2010
2	CytokinesIBA 04/2014 - 01/2003
2	Histone Deacetylase InhibitorsIBA 02/2014 - 07/2013
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2014 - 01/2003
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2011 - 04/2009
2	HLA-DR Antigens (HLA-DR)IBA 04/2011 - 03/2010
2	Caspase 9IBA 01/2008 - 12/2007
2	7-aminoactinomycin DIBA 07/2005 - 09/2003
2	Fluorescent Dyes (Fluorescent Probes)IBA 07/2005 - 02/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2003 - 01/2003
1	LectinsIBA 09/2021
1	NEO2734IBA 08/2021
1	enasidenibIBA 01/2021
1	ivosidenibIBA 01/2021
1	RNA Splicing FactorsIBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	cc-486IBA 12/2020
1	AcidsIBA 12/2020
1	RetinoidsIBA 12/2020
1	Arsenic Trioxide (Trisenox)FDA Link 12/2020
1	PanobinostatIBA 01/2020
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 01/2019
1	Bispecific AntibodiesIBA 01/2019
1	fms-Like Tyrosine Kinase 3IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Amsacrine (AMSA)IBA 03/2017
1	Carboxylic Ester HydrolasesIBA 02/2016
1	Carboxylesterase (Hydrolase S)IBA 02/2016
1	EsterasesIBA 02/2016
1	ProdrugsIBA 02/2016
1	PlasticsIBA 02/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2015
1	Phosphotransferases (Kinase)IBA 09/2014
1	ponatinibIBA 09/2014
1	EpitopesIBA 04/2014

Therapy/Procedure

32	Therapeutics 01/2021 - 07/2002
28	Drug Therapy (Chemotherapy) 01/2021 - 07/2002
12	Immunotherapy 01/2019 - 03/2004
11	Stem Cell Transplantation 01/2021 - 07/2005
7	Surgical Instruments (Clip) 06/2014 - 08/2004
5	Hematopoietic Stem Cell Transplantation 12/2020 - 03/2007
3	Induction Chemotherapy 12/2020 - 10/2005
2	Transplantation 04/2011 - 03/2007
2	Investigational Therapies (Experimental Therapy) 01/2011 - 01/2010
1	Precision Medicine 01/2021
1	Homologous Transplantation 01/2016